RUBEN D CARRASCO, MD PHD
Medical Practice at Francis St, Boston, MA

License number
Massachusetts 204589
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address 2
75 Francis St, Boston, MA 02115
111 Cypress St, Brookline, MA 02445
Phone
(617) 525-7962
(617) 713-2239

Personal information

See more information about RUBEN D CARRASCO at radaris.com
Name
Address
Phone
Ruben Carrasco
79 Park St #3, Brookline, MA 02446
Ruben Carrasco, age 68
79 Park St, Brookline, MA 02446
(617) 738-2909
Ruben D Carrasco, age 68
201 Davis Ave, Brookline, MA 02445
(617) 731-9834

Professional information

Ruben D Carrasco Photo 1

Dr. Ruben D Carrasco, Boston MA - MD (Doctor of Medicine)

Specialties:
Hematology, Hematopathology
Address:
BRIGHAM & WOMENS HOSPITAL
75 Francis St, Boston 02115
(617) 732-5500 (Phone), (617) 731-5453 (Fax)
Certifications:
Anatomic Pathology, 2001, Hematology & Pathology, 2001
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
BRIGHAM & WOMENS HOSPITAL
75 Francis St, Boston 02115
Brigham and Women's Hospital
75 Francis St, Boston 02115
Education:
Medical School
University Of Chile Faculty Of Med Sciences
Graduated: 1982
Brigham And Women'S Hospital
Mass Gen Hospital


Ruben D Carrasco Photo 2

Ruben D Carrasco, Boston MA

Specialties:
Pathologist
Address:
44 Binney St, Boston, MA 02115
75 Francis St, Boston, MA 02115
Education:
Doctor of Medicine
Board certifications:
American Board of Pathology Certification in Anatomic Pathology (Pathology), American Board of Pathology Sub-certificate in Hematology (Pathology)


Ruben Daniel Carrasco Photo 3

Ruben Daniel Carrasco, Boston MA

Specialties:
Pathology, Anatomic Pathology, Hematology, Anatomic Pathology & Clinical Pathology
Work:
Dana-Farber Cancer Institute
450 Brookline Ave, Boston, MA 02215 Dana-Farber Cancer Institute
44 Binney St, Boston, MA 02115 Brigham and Women's Hospital
75 Francis St, Boston, MA 02115
Education:
Universidad De Chile (1982)


Ruben Carrasco Photo 4

Compositions, Kits, And Methods For Identification, Assessment, Prevention, And Therapy Of Cancer

US Patent:
8211634, Jul 3, 2012
Filed:
Feb 13, 2007
Appl. No.:
11/706155
Inventors:
Ronald A. DePinho - Houaton TX, US
Kenneth C. Anderson - Wellesley MA, US
Ruben D. Carrasco - Brookline MA, US
Giovanni Tonon - Cernusco Sul Naviglio, IT
Cameron W. Brennan - Haworth NJ, US
Lynda Chin - Houston TX, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
Board of Trustees of the University of Arkansas - Little Rock AR
International Classification:
C12Q 1/68, G01N 33/53, G01N 33/574
US Classification:
435 6, 434 71, 434 723
Abstract:
The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human cancer. A variety of chromosomal regions (MCRs) and markers corresponding thereto, are provided, wherein alterations in the copy number of one or more of the MCRs and/or alterations in the amount, structure, and/or activity of one or more of the markers is correlated with the presence of cancer.


Ruben Carrasco Photo 5

Compositions, Kits, And Methods For Identification, Assessment, Prevention, And Therapy Of Cancer

US Patent:
2013007, Mar 21, 2013
Filed:
May 17, 2012
Appl. No.:
13/473969
Inventors:
Ronald A. DePinho - Houston TX, US
Kenneth C. Anderson - Wellesley MA, US
Ruben D. Carrasco - Brookline MA, US
Giovanni Tonon - Cernusco Sul Naviglio, IT
Cameron Brennan - Haworth NJ, US
Lynda Chin - Houston TX, US
Assignee:
Board of Trustees of the University of Arkansas - Little Rock AR
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
C40B 30/06, C12Q 1/68, G01N 33/574
US Classification:
506 9, 435 613, 435 611, 435 612, 435 792, 435 71, 435 74, 435 723
Abstract:
The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human cancer. A variety of chromosomal regions (MCRs) and markers corresponding thereto, are provided, wherein alterations in the copy number of one or more of the MCRs and/or alterations in the amount, structure, and/or activity of one or more of the markers is correlated with the presence of cancer.